Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 19, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	76,004	93,403	77,057	66,029	50,990	41,049
Market Cap Growth	30.12%	21.21%	16.70%	29.49%	24.22%	1.64%
Enterprise Value	60,513	80,414	66,767	57,309	47,783	35,796
Last Close Price	714.62	878.29	721.49	631.52	483.11	375.48
PE Ratio	17.68	23.62	17.76	8.18	14.51	19.40
Forward PE	14.89	19.36	17.29	11.00	14.28	13.81
PS Ratio	5.55	7.12	6.33	4.11	6.00	6.26
PB Ratio	2.63	3.60	3.40	3.52	4.62	3.70
P/TBV Ratio	4.02	3.75	3.54	3.52	4.62	3.70
P/FCF Ratio	22.12	24.10	17.41	10.11	25.45	20.52
P/OCF Ratio	17.92	20.33	15.37	9.32	19.48	16.89
PEG Ratio	0.84	4.75	-	-	1.55	1.26
EV/Sales Ratio	4.37	6.13	5.48	3.57	5.62	5.46
EV/EBITDA Ratio	13.16	17.28	12.51	6.17	12.25	14.79
EV/EBIT Ratio	14.66	19.00	13.37	6.37	13.04	16.20
EV/FCF Ratio	17.59	20.75	15.09	8.78	23.85	17.89
Debt / Equity Ratio	0.09	0.11	0.12	0.14	0.24	0.06
Debt / EBITDA Ratio	0.59	0.60	0.52	0.29	0.69	0.29
Debt / FCF Ratio	0.79	0.72	0.63	0.41	1.35	0.36
Asset Turnover	0.40	0.42	0.45	0.75	0.53	0.49
Inventory Turnover	2.44	2.51	2.37	2.74	2.26	2.51
Quick Ratio	4.34	4.82	4.16	2.98	2.86	2.86
Current Ratio	5.28	5.69	5.06	3.56	3.63	3.67
Return on Equity (ROE)	17.17%	16.26%	20.94%	54.21%	31.77%	21.32%
Return on Assets (ROA)	7.41%	8.49%	11.42%	26.39%	14.33%	10.41%
Return on Capital (ROIC)	8.65%	9.76%	13.31%	31.95%	17.95%	12.99%
Earnings Yield	6.12%	4.23%	5.63%	12.23%	6.89%	5.15%
FCF Yield	4.52%	4.15%	5.74%	9.89%	3.93%	4.87%
Buyback Yield / Dilution	-1.16%	-0.18%	-1.16%	2.52%	-0.44%	0.17%
Total Shareholder Return	-1.16%	-0.18%	-1.16%	2.52%	-0.44%	0.17%

Source: S&P Capital IQ. Standard template. Financial Sources.